![Walter Capone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Walter Capone
Directeur Général chez
CAEREGEN THERAPEUTICS, LLC
Profil
Walter M.
Capone is currently the President & Chief Executive Officer at Caeregen Therapeutics LLC.
Previously, he held positions such as Director-Infectious Diseases & Immunology at Bristol-Myers Squibb World Wide Medicines Group, Vice President-Marketing & Product Development at Triangle Pharmaceuticals, Inc., and VP-Commercial Development & Operations at Progenics Pharmaceuticals, Inc. He was also the Senior Vice President-Commercial Operations at Trimeris, Inc. from 2002 to 2007.
In addition, he served as the Chief Business Officer at GeneCentric Therapeutics, Inc. from 2017 to 2021.
He has also worked as a Venture Partner at Boston Millennia Partners and as the Chief Financial Officer & VP-Commercial Operations at TherapyEdge, Inc. Furthermore, he was the President of The Multiple Myeloma Research Foundation, Inc. from 2013 to 2014.
Mr. Capone received his undergraduate degree from Brown University and his MBA from Columbia Business School.
Postes actifs de Walter Capone
| Sociétés | Poste | Début |
|---|---|---|
CAEREGEN THERAPEUTICS, LLC
 CAEREGEN THERAPEUTICS, LLC BiotechnologyHealth Technology Operates as a biotechnology and regenerative medicine company | Directeur Général | 01/09/2022 |
Anciens postes connus de Walter Capone
| Sociétés | Poste | Fin |
|---|---|---|
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. BiotechnologyHealth Technology Operates as an oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression | Corporate Officer/Principal | 03/02/2021 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Corporate Officer/Principal | 01/01/2007 |
Boston Millennia Partners
 Boston Millennia Partners Investment ManagersFinance BMP invests in companies located in the United States with revenue of USD 1 - 20 million and an enterprise value of less than USD 50 million. The firm focuses on the healthcare, business services and information technology sectors. It provides financing for early and growth stage capital transactions with an investment size of USD 0.1 - 3 million. The firm makes follow on investments and acts as a lead investor. | Private Equity Investor | - |
The Multiple Myeloma Research Foundation, Inc.
 The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Directeur Général | - |
Bristol-Myers Squibb World Wide Medicines Group
 Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | - |
Formation de Walter Capone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antiviral drug candidates | Commercial Services |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. BiotechnologyHealth Technology Operates as an oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Millennia Partners
Boston Millennia Partners Investment ManagersFinance BMP invests in companies located in the United States with revenue of USD 1 - 20 million and an enterprise value of less than USD 50 million. The firm focuses on the healthcare, business services and information technology sectors. It provides financing for early and growth stage capital transactions with an investment size of USD 0.1 - 3 million. The firm makes follow on investments and acts as a lead investor. | Finance |
TherapyEdge, Inc.
 TherapyEdge, Inc. Internet Software/ServicesTechnology Services Provides database for HIV patient's clinical records | Technology Services |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Commercial Services |
Bristol-Myers Squibb World Wide Medicines Group
Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CAEREGEN THERAPEUTICS, LLC
CAEREGEN THERAPEUTICS, LLC BiotechnologyHealth Technology Operates as a biotechnology and regenerative medicine company | Health Technology |
